Impact of older age on the long-term survival in living-donor liver transplantation: A propensity score matching analysis

Asian J Surg. 2022 Nov;45(11):2239-2245. doi: 10.1016/j.asjsur.2021.11.061. Epub 2021 Dec 24.

Abstract

Background: Prevalence of the end-stage liver disease in the elderly patients indicating a liver transplantation (LT) has been increasing. There is no universally accepted upper age limit for LT candidates but the functional status of older patients is important in pre-LT evaluation. This study aimed to examine the impact of older age on survival after living donor liver transplantation (LDLT).

Method: A total of 171 LDLT recipients were assessed in two groups: age ≥65 and < 65. To eliminate selection bias propensity score matching (PSM) was performed, and 56 of 171 recipients were included in this study.

Results: There were 20 recipients in the older group and 36 in the younger. The 1-, 3-, and 5-year survival rates were 65.0%, 60.0%, and 60.0% in group 1; 88.9%, 84.7%, and 71.4% in group 2, respectively. The 1-year survival was significantly lower in the older recipients; however, overall survival rates were similar between the groups. Of the 56 recipients, 15 (27%) deaths were observed in overall, and 11 (20%) in 1-year follow-up. The univariate regression analysis after PSM revealed that MELD score affected 1- year survival and the multivariate analysis revealed that age ≥65 years and MELD score were the predictors of 1-year survival.

Conclusion: At first sight, before PSM, survival appeared to be worse for older recipients. However, we have shown that there were confounding effects of clinical variables in the preliminary evaluation. After the elimination of this bias with PSM, This study highlights that older recipients have similar outcomes as youngers in LDLT for long-term survival.

Keywords: Aging; Differential mortality; Elderly; Liver transplantation; Survival.

MeSH terms

  • Aged
  • End Stage Liver Disease* / surgery
  • Graft Survival
  • Humans
  • Liver Transplantation*
  • Living Donors
  • Propensity Score
  • Retrospective Studies
  • Treatment Outcome